What is the future of NK cells?
I think within 5 or 6 years from today, it will be the dominating treatment. Both as, bispecific trispecific and as a car, phenomena. but that's, that is just my advanced guessing. We need to show the data you hear as a patient about Car-T, because large pharma companies own these, drugs or, treatment regimes but, the NK cells are under development. I know that BMS will start a trial study in myeloma, utilizing the functional NK cells.
And we will start this study, in September this year at my site. So there are several companies also starting thinking the same thing. Why not NK cells. Why why just T cells.
It's really hard to know. You have to sort of see where the data leads. It's possible that the, prior treatment with daratumumab may affect the ability to, you know, collect and, manufacture car NK cells, but I think that isn't really known.
HealthTree • May 1, 2023
